ResMed (RMD) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $224.46 --0%
Financial Fact:
Other, net (note 12): 1.27M
Today's EPS Names:
VISL, GNLN, AFIB, More
Financial Fact:
Other, net (note 12): 1.27M
Today's EPS Names:
VISL, GNLN, AFIB, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q3 EPS of $0.65, in-line with the analyst estimate of $0.65. Revenue for the quarter came in at $422.5 million versus the consensus estimate of $425.76 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Helius Medical Technologies (HSDT) Misses Q2 EPS by 31c
- Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
